119 related articles for article (PubMed ID: 21621826)
1. Acquired factor VIII inhibitor as presentation of chronic myelogenous leukemia during interferon-alpha therapy.
Zheng WL; Zhang GS; Shen JK; Pei MF; Peng HL; Xu M
Thromb Res; 2011 Aug; 128(2):202-3. PubMed ID: 21621826
[No Abstract] [Full Text] [Related]
2. Fatal bone marrow aplasia during interferon-a treatment in chronic myelogenous leukemia.
Chiusolo P; Sica S; Laurenti L; Piccirillo N; Giordano G; Leone G
Haematologica; 2000 Feb; 85(2):212. PubMed ID: 10681733
[No Abstract] [Full Text] [Related]
3. Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia.
Fiorani C; Sacchi S; Bonacorsi G; Cosenza M
Haematologica; 2000 Sep; 85(9):1006-7. PubMed ID: 10980653
[No Abstract] [Full Text] [Related]
4. Successful pregnancy occurring with interferon-alpha therapy in chronic myeloid leukemia.
Mesquita MM; Pestana A; Mota A
Acta Obstet Gynecol Scand; 2005 Mar; 84(3):300-1. PubMed ID: 15715542
[No Abstract] [Full Text] [Related]
5. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
Hughes TP; Kaeda J; Branford S; Rudzki Z; Hochhaus A; Hensley ML; Gathmann I; Bolton AE; van Hoomissen IC; Goldman JM; Radich JP;
N Engl J Med; 2003 Oct; 349(15):1423-32. PubMed ID: 14534335
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic myeloid leukemia with interferon-alpha].
Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
[TBL] [Abstract][Full Text] [Related]
8. [Marked reduction of BCR-ABL fusion chromosome positive cells with interferon therapy combined with short-term imatinib in chronic myelogenous leukemia].
Ajima A; Takayama N; Hasegawa Y; Kojima H; Nagasawa T
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1997-9. PubMed ID: 14650975
[TBL] [Abstract][Full Text] [Related]
9. Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia.
Budak-Alpdoğan T; Lawrence RA; Bayik M; Akoğlu E
Clin Nephrol; 1997 Jul; 48(1):59-60. PubMed ID: 9247783
[No Abstract] [Full Text] [Related]
10. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
Bremer CT; Lastrapes A; Alper AB; Mudad R
Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia.
Ladoyanni E; Nambi R
J Drugs Dermatol; 2005; 4(2):221-2. PubMed ID: 15776781
[TBL] [Abstract][Full Text] [Related]
12. [The role of alpha-interferon therapy in chronic myeloid leukemia].
Udvardy M
Orv Hetil; 2000 Jan; 141(2):67-70. PubMed ID: 10686779
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha induced autoimmune hepatitis in a patient with Philadelphia chromosome-positive chronic myeloid leukemia with cytogenetically normal T lymphocytes.
Ariad S; Song E; Cohen R; Bezwoda WR
Mol Biother; 1992 Sep; 4(3):139-42. PubMed ID: 1445668
[TBL] [Abstract][Full Text] [Related]
14. [Treatment with interferon alpha of the lymphoblastic transformation of chronic myeloid leukemia].
Canales MA; Martínez J; Quevedo E; Hernández-Navarro F
Sangre (Barc); 1999 Dec; 44(6):493-4. PubMed ID: 10822770
[No Abstract] [Full Text] [Related]
15. [Effectiveness of treatment with native alpha-interferon (Wellferon) in patients with chronic myeloid leukemia].
Rukavitsyn OA
Vopr Onkol; 1997; 43(6):606-9. PubMed ID: 9479361
[No Abstract] [Full Text] [Related]
16. Interferon-alpha therapy for chronic myeloid leukemia during pregnancy.
Regierer AC; Schulz CO; Kuehnhardt D; Flath B; Possinger K
Am J Hematol; 2006 Feb; 81(2):149-50. PubMed ID: 16432865
[No Abstract] [Full Text] [Related]
17. [The effectiveness of interferon-alpha therapy in Ph-positive chronic myeloid leukemia].
Bogdanov KV; Frolova OI; Marinets OV; Ogorodnikova IuS; Afanas'ev BV; Zaritskiĭ AIu
Vopr Onkol; 2003; 49(2):189-92. PubMed ID: 12785203
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
[TBL] [Abstract][Full Text] [Related]
19. Interferon therapy in chronic myelogenous leukemia.
Guilhot F; Roy L; Guilhot J; Millot F
Hematol Oncol Clin North Am; 2004 Jun; 18(3):585-603, viii. PubMed ID: 15271394
[TBL] [Abstract][Full Text] [Related]
20. Role of interferon-alpha in chronic myeloid leukemia.
Kumar L; Basade M; Gulati SC
J Assoc Physicians India; 1995; Suppl 3():26-32. PubMed ID: 8773119
[No Abstract] [Full Text] [Related]
[Next] [New Search]
